Supplement GMP seminars
This article was originally published in The Tan Sheet
Executive Summary
Small businesses encouraged to attend an afternoon session of FDA's supplement GMP seminars, which will "provide small businesses an opportunity to ask questions about the proposed rule" and offer guidance on submitting comments, FDA says in March 28 Federal Register. Morning session, targeting all interested parties, will provide an overview of the proposed rule while specifically addressing consumer complaints, personnel, physical plant issues, utensils and equipment, holding and distributing, production and process controls, and recordkeeping. The East Coast meeting will take place at CFSAN's building in College Park, Md. April 29, while the West Coast meeting will convene May 6 at the Ronald V. Dellums Federal Building in Oakland, Calif. (1"The Tan Sheet" March 17, 2003, p. 8)...
You may also be interested in...
Roche/Genentech Keeps Commitment To External Cancer Innovation
Roche/Genentech oncology partnering maintained a robust dealmaking pace through the pandemic, keeping the percentage of partnered R&D programs at about 50% of the cancer drug pipeline.
US FDA Eases Changes For Certain Sterile Injectable Container Closure Materials
To mitigate pandemic disruption of component supply chains, the US FDA said it will downgrade some post-approval change categories for sterile drug container closure systems. The downgrade will cover drugs in shortage and those used to treat COVID-19.
Unprecedented To Lawful: Regulatory Precedent Needed For Cannabinoids’ Use In Supplements?
“This is truly uncharted territory because we’ve never had this situation,” says CHPA regulatory VP David Spangle. Asking Congress instead to instruct FDA to first determine a safe daily limit would be a threatening precedent for the supplement market, says CRN CEO Steve Mister. “That really turns DSHEA on its head.”
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: